"Pregnenediones" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Unsaturated pregnane derivatives containing two keto groups on side chains or ring structures.
| Descriptor ID |
D011282
|
| MeSH Number(s) |
D04.210.500.745.745.654
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Pregnenediones".
Below are MeSH descriptors whose meaning is more specific than "Pregnenediones".
This graph shows the total number of publications written about "Pregnenediones" by people in this website by year, and whether "Pregnenediones" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2020 | 5 | 0 | 5 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Pregnenediones" by people in Profiles.
-
Ciclesonide activates glucocorticoid signaling in neonatal rat lung but does not trigger adverse effects in the cortex and cerebellum. Neurobiol Dis. 2021 08; 156:105422.
-
Development of ciclesonide analogues that block SARS-CoV-2 RNA replication. Bioorg Med Chem Lett. 2021 07 01; 43:128052.
-
Prolonged persistence of SARS-CoV-2 infection during A+AVD therapy for classical Hodgkin's lymphoma: A case report. Curr Probl Cancer. 2021 12; 45(6):100739.
-
Visualizing the spatial localization of ciclesonide and its metabolites in rat lungs after inhalation of 1-µm aerosol of ciclesonide by desorption electrospray ionization-time of flight mass spectrometry imaging. Int J Pharm. 2021 Feb 15; 595:120241.
-
A review of Ciclesonide in COVID-19. Still a long way to go. Adv Respir Med. 2021; 89(1):79-81.
-
Successful management of a patient with active Cushing's disease complicated with coronavirus disease 2019 (COVID-19) pneumonia. Endocr J. 2021 Apr 28; 68(4):477-484.
-
The Inhaled Steroid Ciclesonide Blocks SARS-CoV-2 RNA Replication by Targeting the Viral Replication-Transcription Complex in Cultured Cells. J Virol. 2020 12 09; 95(1).
-
Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia. J Microbiol Immunol Infect. 2021 Feb; 54(1):109-112.
-
[Evaluation of Valved Holding Chambers Simulating Repurposing Use of Ciclesonide Metered-dose Inhaler by Patients with Pneumonia]. Yakugaku Zasshi. 2020 Dec 01; 140(12):1495-1500.
-
High levels of anti-SSA/Ro antibodies in COVID-19 patients with severe respiratory failure: a case-based review : High levels of anti-SSA/Ro antibodies in COVID-19. Clin Rheumatol. 2020 Nov; 39(11):3171-3175.